Related Experiment Videos
[High-dose steroid therapy for sudden deafness--efficacy in severe cases]
Y Asada1, H Suzuki, S Nakabayashi
1Department of Otolaryngology, Sendai National Hospital.
Nihon Jibiinkoka Gakkai Kaiho
|October 31, 1998
Summary
High-dose steroid therapy for severe sudden deafness shows a 50% recovery rate. Key factors for better hearing recovery include less severe initial hearing loss, absence of vertigo, and prompt treatment within seven days.
Area of Science:
- Otolaryngology
- Neurology
- Pharmacology
Context:
- Idiopathic sudden sensorineural hearing loss (ISSNHL) is a medical emergency.
- Severe ISSNHL often requires aggressive treatment strategies.
- High-dose steroid therapy is a primary treatment modality for severe ISSNHL.
Purpose:
- To evaluate the efficacy of high-dose steroid therapy (prednisolone 200 mg/day) for severe ISSNHL (≥60 dB hearing loss).
- To identify prognostic factors influencing hearing recovery in patients with severe ISSNHL.
- To assess the impact of initial hearing level, age, vertigo, and treatment delay on treatment outcomes.
Summary:
- A study analyzed 28 patients with severe ISSNHL treated with high-dose intravenous prednisolone.
- The overall hearing recovery rate was 50%, with a 14% cure rate.
- Significant predictors for a higher cure rate included initial hearing levels ≤90 dB, absence of vertigo, age <50 years, and treatment initiation within 7 days.
Impact:
- Identifies crucial prognostic factors for predicting hearing recovery in severe sudden deafness.
- Provides evidence to guide clinical decisions regarding the indication of high-dose steroid therapy for severe ISSNHL.
- Highlights the importance of early intervention and patient-specific factors in managing sudden hearing loss.